Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report
Objective: To report a case with re-emerging neuroleptic malignant syndrome (NMS) without re-introduced neuroleptic drugs. Background: Neuroleptic Malignant Syndrome (NMS) is a potentially fatal idiosyncratic…Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia
Objective: To describe and correlate the apathy and cognitive profile of patients with Parkinson’s disease (PD). Background: Prevalence of apathy in PD is highly variable…Influence of controlled-release levodopa on quality of sleep and nocturnal movements
Objective: To evaluate the effects of controlled-released (CR) levodopa on quality of sleep and nocturnal movements as assessed with mobile health technology in patients with…Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease
Objective: To evaluate the characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease (PD). Background: Lower gastrointestinal tract dysfunction is common in patients…Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease
Objective: To identify if the Montreal Cognitive Assessment (MoCA) is a sensible tool to differentiate cognitive impairment profiles between patients with Essential Tremor (ET) and…Body Representation Impairments in Parkinson’s disease: A Preliminary Report
Objective: The current study investigates semantic processing (SP) and body representation (BR) in early Parkinson’s disease patients (ePDp) compared with neurologically healthy participants. Background: Although…Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies
Objective: To compare motor and neuropathological features of Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) and to determine clinical and neuropathological differences…Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease
Objective: We assessed the role of visual measures and retinal volume (in dopaminergic layers: ganglion cell layer (GCL) and inner plexiform layer (IPL)) to predict…Clinical, motor and global cognition in patients with in early stages of Parkinson disease
Objective: To explore if balance and freezing of gait correlate with global cognition in patients with Parkinson disease in early stages. Background: Early alterations in…Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil
Objective: To determine the impact of cognitive training (CT) on cognitive and quality of life measures in patients with Parkinson's Disease (PD). Background: PD is…
- « Previous Page
- 1
- …
- 117
- 118
- 119
- 120
- 121
- …
- 217
- Next Page »